1. Home
  2. TOUR vs ACET Comparison

TOUR vs ACET Comparison

Compare TOUR & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuniu Corporation

TOUR

Tuniu Corporation

HOLD

Current Price

$0.67

Market Cap

87.0M

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.58

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOUR
ACET
Founded
2006
1947
Country
China
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.0M
71.3M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
TOUR
ACET
Price
$0.67
$8.58
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$65.33
AVG Volume (30 Days)
131.9K
208.6K
Earning Date
03-13-2026
03-05-2026
Dividend Yield
5.45%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$78,261,883.00
N/A
Revenue This Year
$12.27
N/A
Revenue Next Year
$10.18
N/A
P/E Ratio
$101.02
N/A
Revenue Growth
9.07
N/A
52 Week Low
$0.62
$7.15
52 Week High
$1.17
$17.44

Technical Indicators

Market Signals
Indicator
TOUR
ACET
Relative Strength Index (RSI) 40.73 78.42
Support Level $0.62 $7.76
Resistance Level $0.70 $8.55
Average True Range (ATR) 0.03 0.45
MACD -0.00 -0.14
Stochastic Oscillator 1.78 73.85

Price Performance

Historical Comparison
TOUR
ACET

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: